α-Glucosidase and α-amylase inhibition, molecular modeling and pharmacokinetic studies of new quinazolinone-1,2,3-triazole-acetamide derivatives

[1]  B. Larijani,et al.  Benzoylquinazolinone derivatives as new potential antidiabetic agents: α‐Glucosidase inhibition, kinetic, and docking studies , 2020 .

[2]  B. Larijani,et al.  Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors. , 2019, Bioorganic chemistry.

[3]  U. Rashid,et al.  Calotropis procera: UHPLC-QTOF-MS/MS based profiling of bioactives, antioxidant and anti-diabetic potential of leaf extracts and an insight into molecular docking , 2019, Journal of Food Measurement and Characterization.

[4]  B. Larijani,et al.  Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies. , 2019, Bioorganic chemistry.

[5]  S. Lan,et al.  Inhibitory effects of pu-erh tea on alpha glucosidase and alpha amylase: a systemic review , 2019, Nutrition & Diabetes.

[6]  Yuesheng Dong,et al.  Intervention of Prediabetes by Flavonoids From Oroxylum indicum , 2019, Bioactive Food as Dietary Interventions for Diabetes.

[7]  B. Larijani,et al.  New Biscoumarin Derivatives as Potent α-Glucosidase Inhibitors: Synthesis, Biological Evaluation, Kinetic Analysis, and Docking Study , 2018, Polycyclic Aromatic Compounds.

[8]  B. Larijani,et al.  Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. , 2018, Bioorganic chemistry.

[9]  E. Fernandes,et al.  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors. , 2018, European journal of medicinal chemistry.

[10]  B. Larijani,et al.  Novel quinazolin‐4(3H)‐one linked to 1,2,3‐triazoles: Synthesis and anticancer activity , 2018, Chemical biology & drug design.

[11]  A. Kaczor,et al.  Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Ramsha Sohail,et al.  Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors. , 2017, Bioorganic chemistry.

[13]  Mankun Wei,et al.  Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase. , 2017, Bioorganic & medicinal chemistry.

[14]  H. Wahab,et al.  Synthesis, In vitro and Docking Studies of New Flavone Ethers as α‐Glucosidase Inhibitors , 2016, Chemical biology & drug design.

[15]  Syed Muhammad Kashif,et al.  Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies. , 2015, European journal of medicinal chemistry.

[16]  G. Derosa,et al.  α-Glucosidase inhibitors and their use in clinical practice , 2012, Archives of medical science : AMS.

[17]  A. Ardekani,et al.  Short exposure to collagenase and coculture with mouse embryonic pancreas improve human dermal fibroblast culture , 2012, Biotechnology and applied biochemistry.

[18]  A. Mishra,et al.  A REVIEW ON BIOLOGICAL ACTIVITY OF QUINAZOLINONES , 2012 .

[19]  Suranjana Das,et al.  Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing , 2010, PloS one.

[20]  Torsten Schwede,et al.  The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..

[21]  M. Hattori,et al.  Chlorogenic acid derivatives with alkyl chains of different lengths and orientations: potent alpha-glucosidase inhibitors. , 2008, Journal of medicinal chemistry.

[22]  R. Heine,et al.  Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? , 2006, BMJ : British Medical Journal.

[23]  D. Quiñonero,et al.  Anion‐π Interactions , 2006 .

[24]  H. Kolb,et al.  The growing impact of click chemistry on drug discovery. , 2003, Drug discovery today.

[25]  Robin Taylor,et al.  A new test set for validating predictions of protein–ligand interaction , 2002, Proteins.

[26]  Hee-Seob Lee,et al.  Comparative Study of the Inhibition of α-Glucosidase, α-Amylase, and Cyclomaltodextrin Glucanosyltransferase by Acarbose, Isoacarbose, and Acarviosine–Glucose , 1999 .

[27]  W. Guida,et al.  The art and practice of structure‐based drug design: A molecular modeling perspective , 1996, Medicinal research reviews.